Advertisement
Screener

Nektar Therapeutics (NKTR) Shares Outstanding (Cover Page)

1.9 / 5 stars · 30/81 Roast Me

Nektar Therapeutics Shares Outstanding (Cover Page)

Nektar Therapeutics (NKTR) had Shares Outstanding (Cover Page) of 34.14 million shares as of 2026-08-07, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14

  • 2026-08-07: Entity Common Stock, Shares Outstanding 34.14M shares.
  • 2026-05-01: Entity Common Stock, Shares Outstanding 33.79M shares.
  • 2026-03-11: Entity Common Stock, Shares Outstanding 28.69M shares.
  • 2025-10-31: Entity Common Stock, Shares Outstanding 20.34M shares.
Period endEntity Common Stock, Shares Outstanding
2026-08-0734.14M shares
10-Q · filed 2026-08-14
2026-05-0133.79M shares
10-Q · filed 2026-05-08
2026-03-1128.69M shares
10-K · filed 2026-03-13
2025-10-3120.34M shares
10-Q · filed 2025-11-07
2025-07-3119.02M shares
10-Q · filed 2025-08-08
2025-05-01186.10M shares
10-Q · filed 2025-05-09
2025-02-27186.10M shares
10-K · filed 2025-03-14
2024-11-01184.46M shares
10-Q · filed 2024-11-08
2024-08-02184.08M shares
10-Q · filed 2024-08-09
2024-05-02183.62M shares
10-Q · filed 2024-05-10
2024-02-27183.62M shares
10-K · filed 2024-03-05
2023-10-31190.77M shares
10-Q · filed 2023-11-08
2023-08-01190.12M shares
10-Q · filed 2023-08-09
2023-05-02189.24M shares
10-Q · filed 2023-05-10
2023-02-21189.24M shares
10-K · filed 2023-02-28
2022-10-27187.95M shares
10-Q · filed 2022-11-04
2022-07-29187.40M shares
10-Q · filed 2022-08-05
2022-04-29186.27M shares
10-Q · filed 2022-05-06
2022-02-23186.27M shares
10-K · filed 2022-03-01
2021-10-29184.56M shares
10-Q · filed 2021-11-05
2021-07-30183.80M shares
10-Q · filed 2021-08-06
2021-04-30182.31M shares
10-Q · filed 2021-05-07
2021-02-17182.18M shares
10-K · filed 2021-02-26
2020-10-30179.40M shares
10-Q · filed 2020-11-06
2020-07-31178.90M shares
10-Q · filed 2020-08-07
2020-05-01177.99M shares
10-Q · filed 2020-05-08
2020-02-19177.56M shares
10-K · filed 2020-02-28
2019-11-01175.92M shares
10-Q · filed 2019-11-07
2019-08-01175.27M shares
10-Q · filed 2019-08-09
2019-05-01174.31M shares
10-Q · filed 2019-05-09
2019-02-22174.10M shares
10-K · filed 2019-03-01
2018-11-01173.09M shares
10-Q · filed 2018-11-08
2018-08-03172.47M shares
10-Q · filed 2018-08-09
2018-05-03171.40M shares
10-Q · filed 2018-05-10
2018-02-22160.92M shares
10-K · filed 2018-03-01
2017-11-02157.47M shares
10-Q · filed 2017-11-08
2017-08-03156.33M shares
10-Q · filed 2017-08-09
2017-05-04155.15M shares
10-Q · filed 2017-05-10
2017-02-24153.83M shares
10-K · filed 2017-03-01
2016-10-27152.84M shares
10-Q · filed 2016-11-04
2016-07-28136.73M shares
10-Q · filed 2016-08-04
2016-04-27136.26M shares
10-Q · filed 2016-05-04
2016-02-19135.94M shares
10-K · filed 2016-02-29
2015-10-29133.45M shares
10-Q · filed 2015-11-06
2015-07-30132.37M shares
10-Q · filed 2015-08-06
2015-04-23131.53M shares
10-Q · filed 2015-05-01
2015-02-20131.38M shares
10-K · filed 2015-02-26
2014-10-30128.44M shares
10-Q · filed 2014-11-07
2014-07-24127.30M shares
10-Q · filed 2014-08-01
2014-04-30126.98M shares
10-Q · filed 2014-05-08
2014-02-20126.65M shares
10-K · filed 2014-02-27
2013-10-31116.12M shares
10-Q · filed 2013-11-07
2013-08-01115.76M shares
10-Q · filed 2013-08-09
2013-04-30115.52M shares
10-Q · filed 2013-05-09
2013-02-21115.29M shares
10-K · filed 2013-03-01
2012-11-05115.17M shares
10-Q · filed 2012-11-09
2012-08-06114.91M shares
10-Q · filed 2012-08-09
2012-04-27114.61M shares
10-Q · filed 2012-05-04
2012-02-24114.53M shares
10-K · filed 2012-02-29
2011-10-31114.43M shares
10-Q · filed 2011-11-04
2011-08-01114.42M shares
10-Q · filed 2011-08-05
2011-04-25114.07M shares
10-Q · filed 2011-04-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Generate Biomedicines, Inc. (GENB)United States$2.052B
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89